Ontology highlight
ABSTRACT: Purpose
Estimating the incremental costs of scaling-up novel technologies in low-income and middle-income countries is a methodologically challenging and substantial empirical undertaking, in the absence of routine cost data collection. We demonstrate a best practice pragmatic approach to estimate the incremental costs of new technologies in low-income and middle-income countries, using the example of costing the scale-up of Xpert Mycobacterium tuberculosis (MTB)/resistance to riframpicin (RIF) in South Africa.Materials and methods
We estimate costs, by applying two distinct approaches of bottom-up and top-down costing, together with an assessment of processes and capacity.Results
The unit costs measured using the different methods of bottom-up and top-down costing,
SUBMITTER: Cunnama L
PROVIDER: S-EPMC5066665 | biostudies-literature | 2016 Feb
REPOSITORIES: biostudies-literature